Watch MIRA. Know when insiders buy.
One email the day a filing lands. Free.
MIRA
MIRA PHARMACEUTICALS, INC.
0.83
+0.07 +9.62%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
57
WATCH · shorts 57
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $35MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$9.5MNET CASH —52W 0.61 – 1.80SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q 2026 · Jun 30 | — | — | — | — | −$1.2M | — | -0.03 | −$1.2M | — | — | Aug 12 |
| Q 2026 · Mar 31 | — | — | — | — | −$1.2M | — | -0.03 | −$1.2M | — | — | Aug 12 |
| Q 2025 · Dec 31derived | — | — | — | — | −$6M | — | 0.10 | −$1.1M | — | — | Mar 31 |
| Q 2025 · Sep 30 | — | — | — | — | −$1.1M | — | -1.18 | −$1.1M | — | — | Nov 13 |
| Q 2025 · Jun 30 | — | — | — | — | −$1.5M | — | -0.09 | −$800K | — | — | Aug 12 |
| Q 2025 · Mar 31 | — | — | — | — | −$1.8M | — | -0.11 | −$1.6M | — | — | Aug 12 |
| Q 2024 · Dec 31derived | — | — | — | — | −$2.4M | — | -0.15 | −$1.8M | — | — | Mar 31 |
| Q 2024 · Sep 30 | — | — | — | — | −$2M | — | -0.14 | −$1.8M | — | — | Nov 13 |
| Q 2024 · Jun 30 | — | — | — | — | −$1.7M | — | -0.11 | −$864K | — | — | Nov 13 |
| Q 2024 · Mar 31 | — | — | — | — | −$1.7M | — | -0.15 | −$1M | — | — | Nov 13 |
| Q 2023 · Dec 31derived | — | — | — | — | −$5.8M | — | -0.40 | −$1M | — | — | Mar 28 |
| Q 2023 · Sep 30 | — | — | — | — | −$3.6M | — | -0.26 | −$1.8M | — | — | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | — | −$10.4M | — | -1.35 | −$4.7M | — | — | — | — |
| FY2024 · to Dec 31 | — | — | — | −$7.9M | — | -0.51 | −$5.6M | — | — | — | — |
| FY2023 · to Dec 31 | — | — | — | −$12M | — | -0.85 | −$4.5M | — | — | — | — |
| FY2022 · to Dec 31 | — | — | — | −$7.1M | — | -0.40 | −$5.6M | — | — | — | — |
Every number comes from MIRA PHARMACEUTICALS, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.